2,298
Participants
Start Date
October 3, 2022
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Seattle protocol
Participants undergo 4-quadrant biopsies with standard biopsy forceps taken at 2 cm intervals. For participants undergoing a confirmatory endoscopy for cases in which discordant results are noted (WATS3D positive for dysplasia/cancer and Seattle biopsy negative for dysplasia/cancer), repeat biopsies will be taken at 1 cm intervals along with target biopsies from any visible lesions.
WATS3D brushings
Participants undergo 2 WATS3D biopsies of every 5 cm segment of Barrett's esophagus, starting from the gastroesophageal junction and moving proximally through the entire segment of Barrett's.
RECRUITING
Weill Cornell Medicine, New York
RECRUITING
Long Island Jewish Medical Center, New Hyde Park
RECRUITING
University of Rochester, Rochester
RECRUITING
Geisinger Medical Center, Danville
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Suncoast Endoscopy of Sarasota, Sarasota
RECRUITING
Gastrointestinal Associates, PC, Knoxville
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Northwestern University, Chicago
RECRUITING
University of Colorado Anschutz Medical Campus, Aurora
RECRUITING
Arizona Centers of Digestive Health, Gilbert
RECRUITING
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
RECRUITING
Kaiser Permanente, Oakland
RECRUITING
Connecticut Clinical Research Institute, Bristol
University of Colorado, Denver
OTHER